Literature DB >> 22869412

Prevalence of human papillomavirus infection in young women receiving the first quadrivalent vaccine dose.

Lea E Widdice, Darron R Brown, David I Bernstein, Lili Ding, Deesha Patel, Marcia Shew, J Dennis Fortenberry, Jessica A Kahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22869412      PMCID： PMC4042006          DOI： 10.1001/archpediatrics.2012.586

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN： 1072-4710


× No keyword cloud information.
  6 in total

1.  Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic.

Authors:  Darron R Brown; Denise Legge; Brahim Qadadri
Journal:  Sex Transm Dis       Date:  2002-12       Impact factor: 2.830

2.  Determinants of genital human papillomavirus infection in young women.

Authors:  C Ley; H M Bauer; A Reingold; M H Schiffman; J C Chambers; C J Tashiro; M M Manos
Journal:  J Natl Cancer Inst       Date:  1991-07-17       Impact factor: 13.506

3.  Natural history of multiple human papillomavirus infections in female adolescents with prolonged follow-up.

Authors:  Bree Weaver; Marcia Shew; Brahim Qadadri; Wanzhu Tu; Yan Tong; Cheryl Denski; J Dennis Fortenberry; Darron Brown
Journal:  J Adolesc Health       Date:  2010-11-12       Impact factor: 5.012

4.  Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States.

Authors:  Sara E Forhan; Sami L Gottlieb; Maya R Sternberg; Fujie Xu; S Deblina Datta; Geraldine M McQuillan; Stuart M Berman; Lauri E Markowitz
Journal:  Pediatrics       Date:  2009-11-23       Impact factor: 7.124

5.  Comparison of adolescent and young adult self-collected and clinician-collected samples for human papillomavirus.

Authors:  Jessica A Kahn; Gail B Slap; Bin Huang; Susan L Rosenthal; Abbigail M Wanchick; Linda M Kollar; Paula A Hillard; David Witte; Pam Groen; David I Bernstein
Journal:  Obstet Gynecol       Date:  2004-05       Impact factor: 7.661

6.  Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study.

Authors:  Jin-Kyoung Oh; Young-Hee Ju; Silvia Franceschi; Wim Quint; Hai-Rim Shin
Journal:  BMC Infect Dis       Date:  2008-01-30       Impact factor: 3.090
  6 in total
  4 in total

Review 1.  Human papillomavirus vaccine for children and adolescents.

Authors:  Marina I Salvadori
Journal:  Paediatr Child Health       Date:  2018-06-12       Impact factor: 2.253

2.  Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance.

Authors:  Marcia L Shew; Aaron C Ermel; Bree A Weaver; Yan Tong; Wanzhu Tu; Laura M Kester; Cheryl Denski; J D Fortenberry; Darron R Brown
Journal:  J Infect Dis       Date:  2013-08-02       Impact factor: 5.226

3.  Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction.

Authors:  Lea E Widdice; David I Bernstein; Eduardo L Franco; Lili Ding; Darron R Brown; Aaron C Ermel; Lisa Higgins; Jessica A Kahn
Journal:  Vaccine       Date:  2019-09-30       Impact factor: 3.641

4.  Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-sexual lifestyle.

Authors:  Kirti Sharma; Atul Kathait; Asha Jain; Karmila Kujur; Shirish Raghuwanshi; Alok Chandra Bharti; Asha Chandola Saklani; Bhudev Chandra Das
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.